Cost-utility and cost-effectiveness analyses of a long-term, high-intensity exercise program compared with conventional physical therapy in patients with rheumatoid arthritis

Arthritis Care and Research

Volumn 53, Issue 1, 2005, Pages 39-47

  Van Den Hout, Wilbert B ^c   De Jong, Zuzana ^c   Munneke, Marten ^a,c   Hazes, Johanna M W ^b,c   Breedveld, Ferdinand C ^c   Vlieland, Theodora P M Vliet ^c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cost effectiveness analysis; Cost utility analysis; Economic evaluation; Exercise classes; Physical therapy; Rheumatoid arthritis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; EXERCISE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEALTH CARE COST; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHYSIOTHERAPY; QUALITY ADJUSTED LIFE YEAR; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADULT; AGED; ARTHRITIS, RHEUMATOID; COST OF ILLNESS; COST-BENEFIT ANALYSIS; EXERCISE THERAPY; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICAL THERAPY MODALITIES;

EID: 13444279885     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20903     Document Type: Article

References (44)

1. Berryman JW. The tradition of the "six things non-natural": exercise and medicine from Hippocrates through ante-bellum America. Exerc Sport Sci Rev 1989;17:515-59.
2. Macera CA, Hootman JM, Sniezek JE. Major public health benefits of physical activity. Arthritis Rheum 2003;49:122-8.
3. Stenstrom CH, Minor MA. Evidence for the benefit of aerobic and strengthening exercise in rheumatoid arthritis. Arthritis Rheum 2003;49:428-34.
4. Wong JB, Ramey DR, Singh G. Long-term morbidity, mortality, and economics of rheumatoid arthritis. Arthritis Rheum 2001;44:2746-9.
5. Bacon PA, Townend JN. Nails in the coffin: increasing evidence for the role of rheumatic disease in the cardiovascular mortality of rheumatoid arthritis. Arthritis Rheum 2001;44: 2707-10.
6. Huusko TM, Korpela M, Karppi P, Avikainen V, Kautiainen H, Sulkava R. Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland. Ann Rheum Dis 2001;60:521-2.
7. Hazes JM, van den Ende CH. How vigorously should we exercise our rheumatoid arthritis patients? Ann Rheum Dis 1996;55:861-2.
8. Van den Ende CHM, Hazes JM, le Cessie S, Mulder WJ, Belfor DG, Breedveld FC, et al. Comparison of high and low intensity training in well controlled rheumatoid arthritis: results of a randomised clinical trial. Ann Rheum Dis 1996;55:798-805.
9. Westby MD. A health professional's guide to exercise prescription for people with arthritis: a review of aerobic fitness activities. Arthritis Rheum 2001;45:501-11.
10. Van den Ende CHM, Vliet Vlieland TPM, Munneke M, Hazes JM. Dynamic exercise therapy for rheumatoid arthritis. Cochrane Database Syst Rev 2000;(2):CD000322.
11. Häkkinen A, Sokka T, Kotaniemi A, Hannonen P. A randomized two-year study of the effects of dynamic strength training on muscle strength, disease activity, functional capacity, and bone mineral density in early rheumatoid arthritis. Arthritis Rheum 2001;44:515-22.
12. De Jong Z, Munneke M, Zwinderman AH, Kroon HM, Jansen A, Ronday KH, et al. Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis: results of a randomized controlled trial. Arthritis Rheum 2003;48:2415-24.
13. Torrance GW. Measurement of health state utilities for economic appraisal: a review. J Health Econ 1986;5:1-30.
14. The EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 1990;16: 199-208.
15. Dolan P. Modeling valuations for EuroQol health states. Med Care 1997;35:1095-108.
16. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-item health survey 1.0. Health Econ 1993;2:217-27.
17. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;21:271-92.
18. Stiggelbout AM, Eijkemans MJ, Kiebert GM, Kievit J, Leer JW, de Haes HJ. The 'utility' of the visual analog scale in medical decision making and technology assessment: is it an alternative to the time trade-off? Int J Technol Assess Health Care 1996;12:291-8.
19. Tijhuis GJ, Jansen SJ, Stiggelbout AM, Zwinderman AH, Hazes JM, Vlieland TP. Value of the time trade off method for measuring utilities in patients with rheumatoid arthritis. Ann Rheum Dis 2000;59:892-7.
20. Wu AW, Jacobson KL, Frick KD, Clark R, Revicki DA, Freedberg KA, et al. Validity and responsiveness of the EuroQol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. Qual Life Res 2002;11:273-82.
21. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45.
22. Siegert GEH, Vleming LJ, Vandenbroucke JP, Cats A. Measurement of disability in Dutch rheumatoid arthritis patients. Clin Rheumatol 1984;3:305-9.
23. Tugwell P, Bombardier C, Buchanan WW, Goldsmith CH, Grace E, Hanna B. The MACTAR Patient Preference Disability Questionnaire: an individualized functional priority approach for assessing improvement in physical disability in clinical trials in rheumatoid arthritis. J Rheumatol 1987;14: 446-51.
24. Verhoeven AC, Boers M, van der Linden S. Validity of the MACTAR questionnaire as a functional index in a rheumatoid arthritis clinical trial. J Rheumatol 2000;27:2801-9.
25. Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
26. Van den Hout WB, Tijhuis GJ, Hazes JM, Breedveld FC, Vliet Vlieland TP. Cost effectiveness and cost utility analysis of multidisciplinary care in patients with rheumatoid arthritis: a randomised comparison of clinical nurse specialist care, inpatient team care, and day patient team care. Ann Rheum Dis 2003;62:308-15.
27. Oostenbrink JB, Koopmanschap MA, Rutten FF. Standardisation of costs: the Dutch manual for costing in economic evaluations. Pharmacoeconomics 2002;20:443-54.
28. Dutch Health Insurance Executive Board. Pharmacotherapeutic compass. Amstelveen: Dutch Health Insurance Executive Board; 1999.
29. Rutten FFH, Ineveld BMv, Ommen Rv, Hout BAv, Huijsman R. Kostenberekening bij Gezondheidsonderzoek: richtlijnen voor de praktijk. Utrecht: Jan van Arkel; 1993.
30. Koopmanschap MA, Rutten FF, van Ineveld BM, van Roijen L. The friction cost method for measuring indirect costs of disease. J Health Econ 1995;14:171-89.
31. O'Brien BJ, Briggs AH. Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods. Stat Methods Med Res 2002;11:455-68.
32. Desgagne A, Castilloux AM, Angers JF, LeLorier J. The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data. Pharmacoeconomics 1998;13: 487-97.
33. Häkkinen A, Sokka T, Kotaniemi A, Kautiainen H, Jappinen I, Laitinen L, et al. Dynamic strength training in patients with early rheumatoid arthritis increases muscle strength but not bone mineral density. J Rheumatol 1999;26:1257-63.
34. Westby MD, Wade JP, Rangno KK, Berkowitz J. A randomized controlled trial to evaluate the effectiveness of an exercise program in women with rheumatoid arthritis taking low dose prednisone. J Rheumatol 2000;27:1674-80.
35. Ubel PA, Hirth RA, Chernew ME, Fendrick AM. What is the price of life and why doesn't it increase at the rate of inflation? Arch Intern Med 2003;163:1637-1.
36. Wolfe F, Hawley DJ. Measurement of the quality of life in rheumatic disorders using the EuroQol. Br J Rheumatol 1997; 36:786-93.
37. Wilson IB. Clinical understanding and clinical implications of response shift. Soc Sci Med 1999;48:1577-88.
38. Bakker C, Hidding A, Linden S, Doorslaer E. Cost effectiveness of group physical therapy compared to individualized therapy for ankylosing spondylitis: a randomized controlled trial. J Rheumatol 1994;21:264-8.
39. Severens JL, Oerlemans HM, Weegels AJ, 't Hof MA, Oostendorp RA, Goris RJ. Cost-effectiveness analysis of adjuvant physical or occupational therapy for patients with reflex sympathetic dystrophy. Arch Phys Med Rehabil 1999;80:1038-43.
40. Sevick MA, Bradham DD, Muender M, Chen GJ, Enarson C, Dailey M, et al. Cost-effectiveness of aerobic and resistance exercise in seniors with knee osteoarthritis. Med Sci Sports Exerc 2000;32:1534-40.
41. Patrick DL, Ramsey SD, Spencer AC, Kinne S, Belza B, Topolski TD. Economic evaluation of aquatic exercise for persons with osteoarthritis. Med Care 2001;39:413-24.
42. Van den Ende CH, Breedveld FC, Dijkmans BA, Hazes JM. The limited value of the Health Assessment Questionnaire as an outcome measure in short term exercise trials. J Rheumatol 1997;24:1972-7.
43. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
44. Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F. The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 1992;35:498-502.